Mobile health intervention to reduce stress in heart disease patients
A MHealth Intervention to Reduce Perceived Stress in Patients with Ischemic Heart Disease
This study is testing a mobile app called 'mindfulHeart' to see if it can help people with heart disease feel less stressed and improve their health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 128 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Essen Academic / other |
| Locations | 1 site (Essen) |
| Trial ID | NCT05846334 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness and cost-efficiency of an mHealth intervention called 'mindfulHeart' aimed at reducing perceived stress in patients diagnosed with ischemic heart disease (IHD). Chronic stress is linked to worsened cardiovascular outcomes, and this study seeks to implement a scalable solution to manage stress through mobile technology. Participants will use the mindfulHeart app to engage in stress-reduction activities over a specified period, with their progress and health outcomes monitored throughout the trial.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals with a confirmed diagnosis of ischemic heart disease who have experienced elevated perceived stress for at least four weeks and have access to an internet-enabled smartphone.
Not a fit: Patients with severe cognitive impairments, significant psychiatric or medical conditions requiring alternative treatments, or those without private internet access may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the quality of life and cardiovascular health of patients with ischemic heart disease by effectively managing stress.
How similar studies have performed: Other studies have shown promise in using mobile health interventions for stress management in various patient populations, suggesting potential success for this approach in ischemic heart disease.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * confirmed diagnosis of IHD * elevated perceived stress for at least 4 weeks * own an Internet-enabled smartphone and know how to use it * have provided written informed consent Exclusion Criteria: * Participants who have severe cognitive impairment and/or communication difficulties that may affect their ability to participate in the study * psychiatric or medical conditions that require alternative treatment * no private internet access
Where this trial is running
Essen
- Westdeutsches Herz- und Gefäßzentrum, Klinik für Kardiologie und Angiologie — Essen, Germany (Recruiting)
Study contacts
- Principal investigator: Julia Lortz, MD — University of Duisburg-Essen
- Study coordinator: Julia Lortz, PD Dr.
- Email: julia.lortz@uk-essen.de
- Phone: +49 201 723
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.